News
Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of ...
Improvements in our understanding of the human genome, technological tools like artificial intelligence, and global ...
The FDA has chosen Dr Vinay Prasad, a professor at UCSF, to lead its Center for Biologics Evaluation and Research.
Meanwhile, health secretary Robert F. Kennedy Jr. and his lieutenants have sent multiple signals in recent weeks that they ...
Leaders at the FDA, HHS and elsewhere are putting guardrails around COVID-19 boosters, which could mean delayed shots or ...
The cells targeted the cancer and eradicated it. Thirteen years later, Whitehead is still cancer-free. Since then, however, ...
Seventy-five years of preparation for an outbreak like that of COVID-19—and yet, the Centers for Disease Control and ...
Opinion
Trump’s strange obsession of appointing the wrong people in the realm of healthcare – PART 3Donald Trump has recently made a range of nominations/appointments in the US health sector. They will influence conventional and so-called alternative medicine (SCAM) in the US and beyond. It ...
PHILADELPHIA -- The next big world war won't be a nuclear war, or a chemical war -- it will be a war with bioweapons, said ...
Vaccine maker Novavax is seeking to convert the 2022 emergency authorization of its Covid-19 vaccine into full approval. Yet ...
A new vaccine developed by Moderna aims to protect against both flu and COVID-19 with just one shot. Early studies suggest ...
Novavax on Thursday tried to calm investors spooked by the delay of full approval of its COVID vaccine shot by U.S.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results